Arteris, Inc. Logo

Arteris, Inc.

AIP

(1.0)
Stock Price

9,48 USD

-41.07% ROA

-447.83% ROE

-7.88x PER

Market Cap.

292.858.473,00 USD

68.7% DER

0% Yield

-65.72% NPM

Arteris, Inc. Stock Analysis

Arteris, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Arteris, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (18%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 ROE

The stock's ROE indicates a negative return (-93.59%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-32.46%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 PBV

The stock's elevated P/BV ratio (6.13x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-17) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Arteris, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Arteris, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Arteris, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Arteris, Inc. Revenue
Year Revenue Growth
2019 31.501.000
2020 31.812.000 0.98%
2021 37.864.000 15.98%
2022 50.378.000 24.84%
2023 53.096.000 5.12%
2023 53.666.000 1.06%
2024 58.300.000 7.95%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Arteris, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 10.051.000
2020 17.020.000 40.95%
2021 30.812.000 44.76%
2022 41.167.000 25.15%
2023 43.988.000 6.41%
2023 45.128.000 2.53%
2024 42.868.000 -5.27%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Arteris, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 2.533.000
2020 7.329.000 65.44%
2021 13.360.000 45.14%
2022 16.367.000 18.37%
2023 17.704.000 7.55%
2023 17.944.000 1.34%
2024 19.312.000 7.08%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Arteris, Inc. EBITDA
Year EBITDA Growth
2019 8.029.000
2020 -4.435.000 281.04%
2021 -20.283.000 78.13%
2022 -25.332.000 19.93%
2023 -26.360.000 3.9%
2023 -32.073.000 17.81%
2024 -26.576.000 -20.68%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Arteris, Inc. Gross Profit
Year Gross Profit Growth
2019 29.639.000
2020 30.321.000 2.25%
2021 34.133.000 11.17%
2022 46.097.000 25.95%
2023 47.976.000 3.92%
2023 46.320.000 -3.58%
2024 50.080.000 7.51%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Arteris, Inc. Net Profit
Year Net Profit Growth
2019 5.839.000
2020 -3.260.000 279.11%
2021 -23.384.000 86.06%
2022 -27.103.000 13.72%
2023 -32.612.000 16.89%
2023 -36.869.000 11.55%
2024 -33.375.996 -10.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Arteris, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 0
2020 0 0%
2021 -1 0%
2022 -1 0%
2023 -1 0%
2023 -1 100%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Arteris, Inc. Free Cashflow
Year Free Cashflow Growth
2019 11.957.000
2020 1.509.000 -692.38%
2021 -1.622.000 193.03%
2022 -7.818.000 79.25%
2023 -17.232.000 54.63%
2023 -3.146.000 -447.74%
2024 264.000 1291.67%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Arteris, Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 12.199.000
2020 2.163.000 -463.99%
2021 -814.000 365.72%
2022 -6.767.000 87.97%
2023 -15.729.000 56.98%
2023 -2.806.000 -460.55%
2024 311.000 1002.25%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Arteris, Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 242.000
2020 654.000 63%
2021 808.000 19.06%
2022 1.051.000 23.12%
2023 1.503.000 30.07%
2023 340.000 -342.06%
2024 47.000 -623.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Arteris, Inc. Equity
Year Equity Growth
2019 -9.430.000
2020 -12.008.000 21.47%
2021 52.904.000 122.7%
2022 37.535.000 -40.95%
2023 22.029.000 -70.39%
2023 15.103.000 -45.86%
2024 5.275.000 -186.31%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Arteris, Inc. Assets
Year Assets Growth
2019 26.823.000
2020 42.736.000 37.24%
2021 120.443.000 64.52%
2022 115.516.000 -4.27%
2023 102.171.000 -13.06%
2023 102.801.000 0.61%
2024 96.371.000 -6.67%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Arteris, Inc. Liabilities
Year Liabilities Growth
2019 36.253.000
2020 54.744.000 33.78%
2021 67.539.000 18.94%
2022 77.981.000 13.39%
2023 80.142.000 2.7%
2023 87.698.000 8.62%
2024 91.096.000 3.73%

Arteris, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.39
Net Income per Share
-0.95
Price to Earning Ratio
-7.88x
Price To Sales Ratio
5.49x
POCF Ratio
-57.44
PFCF Ratio
-48.74
Price to Book Ratio
54.41
EV to Sales
5.21
EV Over EBITDA
-9.26
EV to Operating CashFlow
-55.53
EV to FreeCashFlow
-46.18
Earnings Yield
-0.13
FreeCashFlow Yield
-0.02
Market Cap
0,29 Bil.
Enterprise Value
0,28 Bil.
Graham Number
1.71
Graham NetNet
-1

Income Statement Metrics

Net Income per Share
-0.95
Income Quality
0.14
ROE
-2.81
Return On Assets
-0.37
Return On Capital Employed
-0.78
Net Income per EBT
1.18
EBT Per Ebit
0.9
Ebit per Revenue
-0.62
Effective Tax Rate
-0.08

Margins

Sales, General, & Administrative to Revenue
0.34
Research & Developement to Revenue
0.81
Stock Based Compensation to Revenue
0.28
Gross Profit Margin
0.86
Operating Profit Margin
-0.62
Pretax Profit Margin
-0.56
Net Profit Margin
-0.66

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.13
Free CashFlow per Share
-0.16
Capex to Operating CashFlow
-0.2
Capex to Revenue
0.02
Capex to Depreciation
0.3
Return on Invested Capital
-4.12
Return on Tangible Assets
-0.41
Days Sales Outstanding
62.86
Days Payables Outstanding
16.52
Days of Inventory on Hand
0
Receivables Turnover
5.81
Payables Turnover
22.1
Inventory Turnover
7513000
Capex per Share
0.03

Balance Sheet

Cash per Share
1,19
Book Value per Share
0,14
Tangible Book Value per Share
-0.06
Shareholders Equity per Share
0.14
Interest Debt per Share
0.1
Debt to Equity
0.69
Debt to Assets
0.04
Net Debt to EBITDA
0.51
Current Ratio
1.14
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,03 Bil.
Invested Capital
23317000
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.08
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
1
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Arteris, Inc. Dividends
Year Dividends Growth

Arteris, Inc. Profile

About Arteris, Inc.

Arteris, Inc. provides semiconductor interconnect intellectual property (IP) and IP deployment solutions in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in System-on-Chip (Soc) designs and Network-on-Chip (NoC) interconnect IP. Its products include FlexNoC, a silicon-proven interconnect IP product; FlexNoC Resilience Package, which provides on-chip data protection; Ncore, a silicon-proven and cache coherent interconnect IP product that provides scalable, configurable, and area efficient characteristics; CodaCache, a last-level cache semiconductor IP product; and Physical interconnect aware NoC optimizer, a software tool that estimates physical layout effects during the architecture and logic development stages of an SoC interconnect design; The company also offers FlexWay for IP subsystem interconnect; FlexPSI for All-digital inter chip link; and FlexNoC Physical for linking physical placement and routing tools. In addition, it provides IP deployment software solutions, including specification, design, documentation, artificial intelligence (AI) package, design data intelligence, and harmony trace. The company serves customers in the automotive, AI/machine learning, 5G and wireless communications, data centers, consumer electronics, and other markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

CEO
Mr. Karel Charles Janac
Employee
258
Address
595 Millich Drive
Campbell, 95008

Arteris, Inc. Executives & BODs

Arteris, Inc. Executives & BODs
# Name Age
1 Mr. Karel Charles Janac
Chairman, Chief Executive Officer & President
70
2 Mr. Paul L. Alpern
Executive Vice President, General Counsel & Secretary
70
3 Mr. Ken Way
Executive Vice President of Global Sales
70
4 Ms. Evin Arici Kebebew
Corporate Controller
70
5 Mr. Nicholas Bryan Hawkins FCA
Vice President & Chief Financial Officer
70
6 Dr. Laurent R. Moll
Chief Operating Officer
70
7 Mr. Michal Siwinski
Chief Marketing Officer
70

Arteris, Inc. Competitors